Baxter International Stock Downgraded on Margin Concerns

Shares of Baxter International Inc (NYSE:BAX) are down 2.9% at $34.28, after a downgrade from Morgan Stanley to "underweight" from "equal weight," with a price-target cut to$30 from $39. The firm raised concerns over the medical equipment name's margin goals, noting its financial outlook may be more challenging than previously thought, particularly after its acquisition of Hillrom. On the charts, support at the$33 level kept losses in check over the past couple months. However, overhead pressure at the 60 ...